Literature DB >> 2463971

Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants.

Y X Zhang1, S J Stewart, H D Caldwell.   

Abstract

Monoclonal antibodies exhibiting Chlamydia trachomatis serovar specificity (serovar A, B-Ba, or C) and serogroup specificity (B, intermediate, or C serogroup) were produced and characterized. These antibodies reacted with the major outer membrane protein, recognized epitopes located at the chlamydial cell surface, and passively neutralized chlamydial toxicity for mice. The antibodies should be useful reagents for defining the molecular structure of these protective epitopes, a necessary step toward the development of a subunit or recombinant C. trachomatis vaccine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463971      PMCID: PMC313145          DOI: 10.1128/iai.57.2.636-638.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Serovar determination of Chlamydia trachomatis isolates by using type-specific monoclonal antibodies.

Authors:  W J Newhall; P Terho; C E Wilde; B E Batteiger; R B Jones
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

2.  Purification on renografin density gradients of Chlamydia trachomatis grown in the yolk sac of eggs.

Authors:  L Howard; N S Orenstein; N W King
Journal:  Appl Microbiol       Date:  1974-01

3.  Experimental inclusion conjunctivitis in man: measurements of infectivity and resistance.

Authors:  E Jawetz; L Rose; L Hanna; P Thygeson
Journal:  JAMA       Date:  1965-11-08       Impact factor: 56.272

Review 4.  New knowledge of chlamydiae and the diseases they cause.

Authors:  J T Grayston; S Wang
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

5.  Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide.

Authors:  H D Caldwell; P J Hitchcock
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Antigenic analysis of the major outer membrane protein of Chlamydia spp.

Authors:  H D Caldwell; J Schachter
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

7.  Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.

Authors:  Y X Zhang; S Stewart; T Joseph; H R Taylor; H D Caldwell
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

8.  Chlamydia trachomatis infections in the United States. What are they costing us?

Authors:  A E Washington; R E Johnson; L L Sanders
Journal:  JAMA       Date:  1987-04-17       Impact factor: 56.272

9.  Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization.

Authors:  R S Stephens; M R Tam; C C Kuo; R C Nowinski
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

10.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

View more
  61 in total

1.  Mutagenesis and functional reconstitution of chlamydial major outer membrane proteins: VS4 domains are not required for pore formation but modify channel function.

Authors:  E S Hughes; K M Shaw; R H Ashley
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 2.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

3.  Immunization with a peptide corresponding to chlamydial heat shock protein 60 increases the humoral immune response in C3H mice to a peptide representing variable domain 4 of the major outer membrane protein of Chlamydia trachomatis.

Authors:  V L Motin; L M de la Maza; E M Peterson
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

4.  Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization.

Authors:  Z D Cui; D Tristram; L J LaScolea; T Kwiatkowski; S Kopti; P L Ogra
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

Review 5.  Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

Authors:  Christina M Farris; Richard P Morrison
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

6.  Association of tubal factor infertility with elevated antibodies to Chlamydia trachomatis caseinolytic protease P.

Authors:  Allison K Rodgers; Jie Wang; Yingqian Zhang; Alan Holden; Blake Berryhill; Nicole M Budrys; Robert S Schenken; Guangming Zhong
Journal:  Am J Obstet Gynecol       Date:  2010-11       Impact factor: 8.661

7.  Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars.

Authors:  Z Qu; X Cheng; L M de la Maza; E M Peterson
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  Characterization of the humoral response induced by a synthetic peptide of the major outer membrane protein of Chlamydia trachomatis serovar B.

Authors:  A Villeneuve; L Brossay; G Paradis; J Hébert
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  An in vitro model for immune control of chlamydial growth in polarized epithelial cells.

Authors:  J U Igietseme; P B Wyrick; D Goyeau; R G Rank
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Immunization with the attenuated plasmidless Chlamydia trachomatis L2(25667R) strain provides partial protection in a murine model of female genitourinary tract infection.

Authors:  Norma Olivares-Zavaleta; William Whitmire; Donald Gardner; Harlan D Caldwell
Journal:  Vaccine       Date:  2009-12-08       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.